| Home | E-Submission | Sitemap | Contact Us |  
Best Practice > About > Best Practice



As an open access journal, the Journal of Neurocritical Care (JNC) will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

Table of Contents

1. Website

The URL of official journal web site is http://www.e-jnc.org.

The JNC team endeavors to make a good website. JNC website demonstrates that care has been taken to ensure high ethical and professional standards. It does not contain any misleading information, including any attempt to mimic another journal/publisher’s site.

2. Name of Journal

The official journal title is Journal of Neurocritical Care, the abbreviation of ISO is J Neurocrit Care.

3. Peer Review Process

The JNC has on online submission and peer review system at https://submit.e-jnc.org.

All papers, including those invited by the Editor, are subject to peer review. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.

• The journal uses a double-blind peer review process: the reviewers do not know the identity of the authors, and vice versa.
• The editorial committee has the right to revise the manuscript without the authors’ consent, unless the revision substantially affects the original content. After review, the editorial board determines whether the manuscript is accepted for publication or not. Once rejected, the manuscript does not undergo another round of review.
• After a manuscript is received by the editorial committee, an e-mail confirmation thereof will be sent to the author within 7 days. The author will be notified of any possible delay that is due to evaluation difficulty. The authors can make an inquiry to the editorial committee on the current evaluation phase of the manuscript. The Board will notify the author on the status of the board review process.

4. Ownership and Management

This journal is owned by the publisher, the Korean Neurocritical Care Society (http://neurocriticalcare.or.kr).

5/6. Governing Body / Editorial Team and Contact Information

The governing body is the journal's editorial board. The full names and affiliations of the journal’s editors and members of journal management team are displayed on the About (Editorial Board & Management Team) tab of journal homepage, and the contact information for the Editor and editorial office is on the About (Contact Us) tab.

7. Copyright and Licensing

Copyright to all published materials is owned by the Korean Neurocritical Care Society. All authors should agree to the copyright transfer during the submission process.

JNC is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of JNC in other journals, books or media for scholarly, educational purposes, the process of permission request to the publisher of JNC is not necessary. All contents of the journal are available immediately upon publication without embargo period.

8. Author Fees

There is no author’s submission fee or other publication-related fees as all publication costs are shouldered by the publisher.

9. Process for Identification of and Dealing with Allegations of Research Misconduct

The editorial board of JNC have carefully examined all submitted manuscripts whether these are abided by the ethical guidelines of the ICMJE and COPE. The published articles have involved the statements of conflict of interest, institutional review board, informed consent, and human/animal rights.

When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the COPE (http://publicationethics.org/resources/flowcharts). The editorial board of JNC will discuss the suspected cases and reach a decision. JNC will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

10. Research & Publication Ethics

JNC follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr).

Our publication ethics are displayed on the Editorial Policy (Publication Ethics) tab of journal homepage.

11. Publishing Schedule

JNC published semiannually (the last day of June and December).

12. Access

JNC is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.

13. Archiving

Full text of JNC has been archived in National Library of Korea (http://www.nl.go.kr). According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk), authors cannot archive pre-print (i.e., pre-refereeing), but they can archive post-print (i.e., final draft post-refereeing). Authors can archive publisher's version/PDF. JNC provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in National Library of Korea.

14. Revenues Sources

Revenue sources of journal are from the support of publisher (Korean Neurocritical Care Society).

15. Advertising

JNC does not accept any commercial product advertisements until policy changes otherwise.

16. Direct Marketing

Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

E-Submission
Endnote Style File
Email Alert
Author's Index
Editorial Office
88, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea
TEL : +82-2-3010-3440    FAX : +82-2-474-4691    E-mail : office@e-jnc.org

Copyright© Korean Neurocritical Care Society. All rights reserved.                Developed in M2community